Sabine Knappe

Title: The Innovations of Sabine Knappe

Introduction

Sabine Knappe is a notable inventor based in Vienna, Austria. She has made significant contributions to the field of medical science, particularly in the area of blood coagulation disorders. With a total of two patents to her name, her work focuses on improving hemostasis and developing effective treatments for bleeding disorders.

Latest Patents

Knappe's latest patents include innovative compositions aimed at enhancing hemostasis in patients with bleeding disorders. One of her patents describes compositions of human prothrombin and activated factor X, which are designed to improve hemostasis and reverse anticoagulant activity. This invention outlines effective ratios of prothrombin (FII) and activated factor X (FXa) that are as efficacious as existing treatments, such as FEIBA®, but require a lower concentration of FII. Another patent focuses on methods and systems for screening compositions comprising non-anticoagulant sulfated polysaccharides. This invention includes methods for identifying suitable NASP (non-anticoagulant sulfated polysaccharide) compositions for treating blood coagulation disorders, evaluating their coagulation activity, chemical makeup, and molecular structure.

Career Highlights

Throughout her career, Knappe has worked with prominent companies in the pharmaceutical industry. She has been associated with Baxalta GmbH and Takeda Pharmaceutical Company Limited, where she has contributed her expertise in developing innovative medical solutions.

Collaborations

Knappe has collaborated with esteemed colleagues, including Michael Dockal and Susanne Till. These partnerships have furthered her research and development efforts in the field of blood coagulation.

Conclusion

Sabine Knappe's contributions to medical science through her patents and collaborations highlight her dedication to improving treatments for bleeding disorders. Her innovative work continues to pave the way for advancements in healthcare.